Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 4 Esophageal Neoplasms 3 Colorectal Neoplasms 3 Stomach Neoplasms 2 Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Recurrence 1 Pinealoma 1 Pancreatic Neoplasms 1 Neoplasms, Glandular and Epithelial 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Locally Advanced Rectal Adenocarcinoma 1 Locally Advanced Cervical Carcinoma 1 Liver Neoplasms 1 Liver Diseases 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Gastric Cancer With Liver Metastases 1 Endometrial Neoplasms 1 Digestive System Neoplasms 1

Interventions

pembrolizumab 27 Cisplatin 18 Cetuximab 12 Carboplatin 12 Surveys and Questionnaires 8 Radiotherapy 8 Paclitaxel 8 Docetaxel 6 Radiotherapy, Intensity-Modulated 5 Surgical Procedures, Operative 4 dostarlimab 3 Therapeutics 3 Standard of Care 3 Fluorouracil 3 Cyclophosphamide 3 Chemoradiotherapy 3 Blood Specimen Collection 3 Albumin-Bound Paclitaxel 3 130-nm albumin-bound paclitaxel 3 toripalimab 2 nimotuzumab 2 fludarabine 2 durvalumab 2 atezolizumab 2 abemaciclib 2 X-Rays 2 Taxes 2 Radiosurgery 2 Radiation 2 Nivolumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Head and Neck Neoplasms × Immunotherapy × 90 days × Clear all

NCT05328024 2026-06-05

IPRICE

Centre Paul Strauss

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡